Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Financial Results
    • Cadila Healthcare Q4...

    Cadila Healthcare Q4 profit rises 53 percent at Rs 590.8 crore

    Written by Ruby Khatun Khatun Published On 2018-05-27T10:30:42+05:30  |  Updated On 27 May 2018 10:30 AM IST
    Cadila Healthcare Q4 profit rises 53 percent at Rs 590.8 crore

    New Delhi: Cadila Healthcare on Friday reported 53.26% jump in consolidated net profit at Rs 590.8 crore for the fourth quarter ended 31 March 2018.


    The company had posted a consolidated net profit of Rs385.5 crore in the same quarter a year ago, Cadila Healthcare said in a BSE filing.


    Consolidated sales for the period under review stood at Rs3,152.7 crore. It was at Rs2,452.7 crore in the fourth quarter previous fiscal. For the year ended 31 March 2018, consolidated net profit was at Rs1,775.8 crore as against Rs1,487.7 crore in 2016-17, up 19.37%.


    Consolidated sales for 2017-18 were at Rs11,630.8 crore. It was at Rs9,363.1 crore in the previous fiscal, the company said.


    The board of directors has recommended a dividend of Rs3.5 per equity share of Re1 each for the fiscal ended 31 March 2018 subject to shareholders’ approval in the ensuing AGM, it added.

    CadilaCadila HealthcaredividendFinancial resultsfourth quarterprofitQ4
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok